Dr. Kelly L. Molpus, MD

Dr. Molpus practices at Halifax Health Medical Center of Daytona Beach in Daytona Beach, Florida, part of Halifax Health District.

Dr. Molpus' NPI, 1699877506, was assigned on September 1, 2006. Dr. Molpus graduated from USF Health Morsani College of Medicine in 1989. Dr. Molpus holds Florida license ME89335.

Dr. Molpus' primary practice is Halifax Health Medical Center of Daytona Beach, at 303 N Clyde Morris Blvd, Daytona Beach, FL 32114 in Volusia County. The practice phone is (386) 254-4000.

Dr. Molpus' primary practice is Halifax Health Medical Center of Daytona Beach in Daytona Beach, Florida, part of Halifax Health District. Dr. Molpus is also affiliated with AdventHealth Daytona Beach. The medical group on file is Halifax Health. Dmand AI also links Dr. Molpus to 1 more hospital and 1 behavioral health center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Molpus practices, 4 sites in all. Vendor and product names are available with a free account.

Gynecologic oncology is Dr. Molpus' primary specialty in the NPI Registry, under taxonomy code 207VX0201X. Dr. Molpus is board certified in gynecologic oncology by the American Board of Obstetrics and Gynecology. Dmand AI has Dr. Molpus' licenses on file in 2 states: Florida and Tennessee.

Dmand AI lists hysterectomy and ovarian cyst among the conditions Dr. Molpus treats.

CMS data shows 125 Medicare services from Dr. Molpus across 5 procedure codes in 2024, for 77 Medicare patients. Medicare paid $9,961 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 77 Medicare patients who saw Dr. Molpus in 2024. The largest group is 65 to 74, with 38 patients. 75% of them have high cholesterol, and 71% have high blood pressure. Their average risk score is 1.25, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Molpus' median patient age at 70, with 99% women.

In 2024, Dr. Molpus wrote 199 Medicare Part D claims for 80 patients. 94% of them were for generic drugs. CMS names the drug for 132 of them, across 6 drugs with 11 or more claims each, at $1,225 in total drug cost. In 2023, CMS named 137 claims across 5 drugs.

Dr. Molpus accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 11 procedures of removal of the uterus by Dr. Molpus, more than 85% of the clinicians it reports for that procedure.

Colonoscopy: 1 to 10 procedures (CMS shows small counts as a range)

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 20 papers to Dr. Molpus, published from 2006 to 2025. The most frequent topics are Ovarian Neoplasms, Endometrial Neoplasms and Hysterectomy. Dr. Molpus has published most often in Gynecol Oncol. Dr. Molpus' most frequent co-authors are Nadeem R. Abu-Rustum, MD, Raheela Ashfaq, FACP, MD and Afshin Bahador, MD.

CMS Open Payments shows 59 general payments to Dr. Molpus from 18 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 84% of the total. Intuitive Surgical, Inc. paid the most, $1,705.

Dr. Molpus graduated from USF Health Morsani College of Medicine in 1989.

Dr. Molpus is in network with 18 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.